{"text": "Specific disruption of NFAT5 or NF-kappaB binding sites in the LTR of HIV-1 subtype B .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "( A ) Mutations introduced into a HIV-1Lai / Bal - <extra_id_0> env <extra_id_2> Protein <extra_id_1> infectious molecular clone .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "NF-kappaB and NFAT5 binding site mutations were introduced into the LTR of the HIV-1Lai / Bal - <extra_id_0> env <extra_id_2> Protein <extra_id_1> - wild type ( WT ) infectious molecular clone .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "The NF-kappaB binding site mutants ( HIV-1Lai / Bal - <extra_id_0> env <extra_id_2> Protein <extra_id_1> - kappaB I-Mut , HIV-1Lai / Bal - <extra_id_0> env <extra_id_2> Protein <extra_id_1> - kappaB II-Mut , HIV-1Lai / Bal - <extra_id_0> env <extra_id_2> Protein <extra_id_1> - kappaB I+II-Mut ) , and NFAT5 binding site mutant ( HIV-1Lai / Bal - <extra_id_0> env <extra_id_2> Protein <extra_id_1> - N5-Mut ) are shown along with the HIV-1Lai / Bal - <extra_id_0> env <extra_id_2> Protein <extra_id_1> - WT sequence .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Mutations were introduced into the 3 ' LTR of the HIV-1Lai / Bal - <extra_id_0> env <extra_id_2> Protein <extra_id_1> - WT proviral sequence .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "( B ) Specific mutation of the NFAT5 binding site abolishes <extra_id_0> NFAT5 <extra_id_2> Protein <extra_id_1> binding to the viral LTR but does not affect NF-kappaB <extra_id_0> p50 <extra_id_2> Protein <extra_id_1> / <extra_id_0> p65 <extra_id_2> Protein <extra_id_1> binding to the overlapping NF-kappaB binding site .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Quantitative <extra_id_0> DNaseI <extra_id_2> Protein <extra_id_1> footprinting analysis is shown using HIV-1 LTR fragments ( -262 to +4 nt relative to the transcription start site ) from HIV-1Lai / Bal - <extra_id_0> env <extra_id_2> Protein <extra_id_1> - WT and HIV-1Lai / Bal - <extra_id_0> env <extra_id_2> Protein <extra_id_1> - N5-Mut and increasing concentrations of recombinant NF-kappaB ( <extra_id_0> p50 <extra_id_2> Protein <extra_id_1> / <extra_id_0> p65 <extra_id_2> Protein <extra_id_1> ) ( 25 ng , 100 ng , and 500 ng ) , or <extra_id_0> NFAT5 <extra_id_2> Protein <extra_id_1> ( 10 ng , 50 ng , and 250 ng ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "The regions that are protected from <extra_id_0> DNase I <extra_id_2> Protein <extra_id_1> cleavage by the binding of NF-kappaB and <extra_id_0> NFAT5 <extra_id_2> Protein <extra_id_1> are indicated with a bars .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "( C ) Specific disruption of the HIV-1 subtype B NF-kappaB binding sites effectively abrogates recombinant <extra_id_0> p50 <extra_id_2> Protein <extra_id_1> / <extra_id_0> p65 <extra_id_2> Protein <extra_id_1> binding .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Quantitative <extra_id_0> DNaseI <extra_id_2> Protein <extra_id_1> footprinting analysis is shown of nucleotides -262 to +4 from HIV-1Lai / Bal - <extra_id_0> env <extra_id_2> Protein <extra_id_1> - WT , HIV-1Lai / Bal - <extra_id_0> env <extra_id_2> Protein <extra_id_1> - kappaB I-Mut , HIV-1Lai / Bal - <extra_id_0> env <extra_id_2> Protein <extra_id_1> - kappaB II-Mut , and HIV-1Lai / Bal - <extra_id_0> env <extra_id_2> Protein <extra_id_1> - kappaB I+II-Mut and increasing concentrations of recombinant NF-kappaB ( <extra_id_0> p50 <extra_id_2> Protein <extra_id_1> / <extra_id_0> p65 <extra_id_2> Protein <extra_id_1> ) ( 25 ng , 100 ng , and 500 ng ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "The regions that are protected from <extra_id_0> DNase I <extra_id_2> Protein <extra_id_1> cleavage by the binding of recombinant NF-kappaB are indicated with a bars .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "( D ) Specific disruption of the HIV-1 subtype B NF-kappaB binding site does not inhibit but enhances <extra_id_0> NFAT5 <extra_id_2> Protein <extra_id_1> binding to this region .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Quantitative <extra_id_0> DNaseI <extra_id_2> Protein <extra_id_1> footprinting analysis is shown of nucleotides -262 to +4 from HIV-1Lai / Bal - <extra_id_0> env <extra_id_2> Protein <extra_id_1> - WT , HIV-1Lai / Bal - <extra_id_0> env <extra_id_2> Protein <extra_id_1> - kappaB I-Mut , HIV-1Lai / Bal - <extra_id_0> env <extra_id_2> Protein <extra_id_1> - kappaB II-Mut , and HIV-1Lai / Bal - <extra_id_0> env <extra_id_2> Protein <extra_id_1> - kappaB I+II-Mut and increasing concentrations of recombinant <extra_id_0> NFAT5 <extra_id_2> Protein <extra_id_1> ( 10 ng , 50 ng , and 250 ng ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "The regions that are protected from <extra_id_0> DNase I <extra_id_2> Protein <extra_id_1> cleavage by the binding of recombinant <extra_id_0> NFAT5 <extra_id_2> Protein <extra_id_1> are indicated with a bars .", "event": "<extra_id_0> <extra_id_1>"}
